# A Clinical Study of FT1 in Patients With Short Bowel Syndrome

> **NCT07704047** · PHASE2 · RECRUITING · sponsor: **Chongqing Peg-Bio Biopharm Co., Ltd.** · enrollment: 8 (estimated)

## Conditions studied

- Short Bowel Syndrome
- SBS

## Interventions

- **DRUG:** FT1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07704047
- **Lead sponsor:** Chongqing Peg-Bio Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-30
- **Primary completion:** 2027-04-15
- **Final completion:** 2027-04-15
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704047, "A Clinical Study of FT1 in Patients With Short Bowel Syndrome". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07704047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*